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Tumour-like ChagaSiC enCephaliTiS 
in aiDS paTienTS
An atypical presentation in one of them and 
outcome in a small series of cases
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Chagas’ disease is an intracellular parasitic infection 
owed to a protozoarium, the Trypanosoma cruzi1, affect-
ing a large population in Latinamerica. Within the region 
15 to 16 million people are infected2. 
The worldwide pandemia, due to the infection of the 
HIV 1 virus, also affects Latinamerican countries. The num-
ber of patients with this condition in Central and South 
Americas amounts to 1.6 million persons3,4. Therefore, 
both illnesses overlap in a broad geographical area and 
may coincide in the same patient.
The HIV infection, which causes the AIDS syndrome, 
impairs the immunological system and predisposes to the 
appearance of opportunistic infections, which may have 
been hosted unnoticed by the patient until then. There-
fore, Chagas’ disease, which is a dormant infection in most 
patients5, may reactivate if the immunological surveillance 
wanes off as the consequence of the viral insult. Along 
the last years we6,7 and others8-10 found patients afflicted 
by AIDS, who developed brain lesions yielded by the Try-
panosoma cruzi.
The present communication describes three further 
patients with this condition; one of them is unique be-
cause his clinical, radiological and immunological findings 
differ from those previously reported in the literature. 
CaSeS
Patient 1
A 28-years-old male. Ten days before admission, he noted 
progressive weakness on the left side of his body followed by 
seizures on the same side which started on his upper limb and 
spread to the left lower limb, lasting 30–40 seconds. The sei-
zures appeared 3 days before admission with a frequency of 
one per day. Simultaneously, he developed a throbbing bilater-
al headache. He also referred a weight loss of about 20 Kg along 
the last four months.
On clinical examination he presented a left-sided hemipare-
sis with hyperactive reflexes. Ordinary laboratory tests were un-
remarkable, except for a very low count of CD4+ lymphocytes, 
which amounted to 70 cells/mm3. Serum ELISA and Western 
Blot were positive for HIV infection and an indirect immunoflu-
orescence assay (IIA) for Toxoplasmosis was positive as well. Se-
rological tests for Chagas’ disease (IIA, ELISA) and a search for 
trypomastigotes in blood were negative.
Fig 1. Patient 1. MRI showing a round lesion at the right parietal lobe 
surrounded by an enhanced gadolinium ring and oedema.
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A brain magnetic resonance (MRI) disclosed a rounded im-
age located at the parietal lobe, which was surrounded by dig-
ital-like oedema pushing aside the lateral ventricle; when gad-
olinium was administered an enhanced ring, encompassing the 
whole lesion, appeared (Fig 1).
Assuming that the lesion was due to toxoplasmosis infection 
the patient was put on pyrimethamine 100 mg/day, clindamycin 
600 mg/qid and leucovorin 15 mg/day. By day 12th after treat-
ment, no improvement of his clinical condition was observed; 
therefore, it was decided to obtain a biopsy of his brain lesion. 
Histological examination of the specimen showed necrotic tis-
sue and macrophages filled with amastigotes.
The diagnosis of Chagas’ disease was done and treatment 
with Benznidazol, 5 mg/kg/day, and antiretroviral therapy were 
started. The patient continued to deteriorate and died 50 days 
after the beginning of the therapy. Autopsy was not permitted. 
 
Patient 2
A 51-years-old male. He came to the clinical office complain-
ing of language disturbances, visual defects and weakness on the 
right side of his body. All the symptoms appeared about ten to 
fifteen days before his assessment and were slowly progressive.
On clinical examination he showed global aphasia, right 
hemianopia, right mild hemiparesis and spasticity.
Regular laboratory tests disclosed a low number of CD4+ 
lymphocytes amounting to 46 cells/mm3. Serum ELISA and 
Western Blot for HIV infection were positive. Serum tests for 
Toxoplasmosis and Chagas’ disease were positive as well. How-
ever, trypomastigotes within the blood were not found.
MRI showed several, spontaneouly enhanced rounded lesions 
on T1-weighted imaging, probably due to blood in their cores, 
distributed along the whole brain, mainly at the boundery be-
tween the cortex and the white matter, surrounded by oedema.
The assumption of toxoplasmosis was done and appropri-
ate treatment was started. At the 4th day after treatment the pa-
tient deteriorated, his weakness became worst and partial motor 
seizures appeared. Biopsy of one of the lesions showed macro-
phages filled with amastigotes. Finally, he developed an epilep-
tic status and died as a consequence of sepsis. Before dying, a 
cerebrospinal fluid (CSF) sample was obtained, where trypomas-
tigotes were found as well.
Patient 3
A 35-years-old male, HIV positive, who had not received an-
tiretroviral therapy. He was admitted into the ward because of 
a sudden weakness on the left side of his body, which had start-
ed ten days before his assessment.
Neurological examination disclosed left-sided weakness and 
mild sensory loss.
Laboratory tests were unremarkable. A computed tomog-
raphy (CT) of his brain showed a hemorrhagic lesion of 50 × 40 
× 26 mm in volume, located at his right parietal lobe. A thor-
ough cardiological examination and clotting blood tests were 
normal.
The patient partially recovered and was discharged with a 
minimal hemiparesis. 
Two months later, he was readmitted because his weakness 
had became progressively worst along the last 2 weeks, and report-
ed a few partial motor seizures and a moderate daily headache.
On clinical examination he showed a mild motor deficit and 
sensory impairment on his left side. Laboratory tests disclosed 
551 CD4+ lymphocytes/mm3 and positive serological tests for 
Fig 2. Patient 3. Biopsy of the right brain parietal lobe nodular lesion showing a macrophage filled 
with amastigotes (hematoxilin-eosin, magnification x400).
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Toxoplasmosis and Chagas’ disease. A first blood sample search-
ing for parasitemia was negative.
MRI showed that the original hemorrhagic lesion was small-
er in size, but a new ring-enhancing lesion, of about 1 cm in di-
ameter, appeared at its edge.
Treatment for toxoplasmosis was started; 7 days later the 
weakness became worst and a new TC disclosed another annu-
lar lesion located at the right basal ganglia. 
A stereotactic biopsy of the parietal nodular lesion was per-
formed; histological examination of the sample showed necrot-
ic tissue and macrophages filled with amastygotes (Fig 2). At 
this time, a new blood examination was able to detect trypo-
mastigotes.
The patient was put on Benznidazol 5 mg/kg/day, and anti-
retroviral drugs (d4T, 3TC and Nelfinavir). He was discharged and 
had a progressive but sustained improvement. MRI, five months 
later, revealed that all lesions had decreased in size. On follow 
up, 14 months after diagnosis, he showed mild motor sequelae 
and negative parasitemia. He is still on Benznidazol treatment. 
DiSCuSSion
The possibility that a dormant T. cruzi infection reac-
tivates in a patient who, simultaneously, is affected by an 
HIV infection is quite reasonable knowing that the para-
site is intracellular and becomes the guest of many cells 
after its innoculation in the acute period of the disease. It 
is noteworthy that the parasites are able to reach the cen-
tral nervous system at the time of their first contact with 
its host11,12 and, thence, most probably, lodge in neurones 
and/or glia cells13,14. In normal conditions, the surveillance 
of the immune system takes control of them, but if for 
any reason the immune system fails, they will be allowed 
to reproduce and leave the host cell5-9. This sort of behav-
iour has been noted in patients whose immune system has 
been weakened by the employment of citotoxic drugs14,15.
In a previous communication7 we described 10 patients 
who had Chagas’ disease and were asymptomatic until 
they were infected by the HIV virus. All of them devel-
oped cerebral tumour-like (pseudotumours) lesions when 
they had less than 126 CD4+ cells/mm3.
The present communication describes other three 
cases. Two of them had quite a similar behaviour than 
those already reported. However, the third patient was 
unique regarding his clinical presentation, the type of le-
sions found, the number of CD4+ cells and his response 
to treatment. 
In regards to the first two patients, they behaved as 
most of the other patients described in the literature6,7,12,16,17 
with a very poor outcome in spite of specific treatment, 
and like most of them, died shortly after diagnosis.
Opposite to this behaviour was the third patient. He 
disclosed several differences with the others. First, his clin-
ical presentation was a lobar hemorrhagic lesion or, per-
haps, a hemorrhagic infarct, which could not be explained 
by any circulatory or blood abnormality. It is worthy to 
note that it has been claimed that in chagasic patients 
brain trombo-embolism may occur in the absence of car-
diac or arterial damage. Whatever the causes of the vascu-
lar event were, after 2 months of the initial manifestation, 
a MRI image suggesting a pseudotumour, was detected. 
We do not know how the former lesion may be re-
lated to the later. The only finding that suggests a con-
nection between them is the fact that they were in close 
proximity, contacting by their edges; one might speculate 
that the parasites, held in the blood of the hemorrhage, 
invaded part of the surronding tissues, later developing 
the pseudotumour. 
The appearance of a third lesion, in the basal ganglia, 
strongly suggested an opportunistic disease and provided 
the rationale for the biopsy procedure, which made the di-
agnosis of Chagas’ disease. The third difference is the num-
ber of CD4+ cells, being normal in this patient and suggest-
ing a healthy state of his immune system. We do not have 
a clear explanation for this, either. Perhaps some type of 
impairment of the immune mechanisms, not reflected by 
the number of CD4+ cells, underlies this behaviour. Finally, 
he is the only one who showed an acceptable response 
to the specific treatment, which is currently sustained. 
Whether this favourable outcome is connected to the nor-
mal CD4+ cells count or not, is a yet unresolved question.
The cases described here, confirm that dormant Cha-
gas’ disease can reactivate in HIV patients in the form of 
brain pseudotumours. They also underline that these le-
sions can be the first opportunistic infection to appear. 
Therefore, Chagas’ disease should be considered an AIDS-
defining illness in Latin America; already some countries, 
Brazil and Argentina amongst them, have adopted this 
conception. Finally, it seems possible that this disease may 
appear in AIDS patients with an apparently normal immu-
nological status, and that the anti-Trypanosoma treatment 
in combination with antiretroviral therapy, in this type of 
patients, may render more encouraging results.
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